Forest Stefanie K, Shirazi Maryam, Wu-Gall Charlotte, Stotler Brie A
From the Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY.
NewYork-Presbyterian Hospital, New York, NY.
Am J Clin Pathol. 2017 Jan 1;147(1):105-109. doi: 10.1093/ajcp/aqw204.
To evaluate the impact that an electronic ordering system has on the rate of rejection of blood type and screen testing samples and the impact on the number of ABO blood-type discrepancies over a 4-year period.
An electronic ordering system was implemented in May 2011. Rejection rates along with reasons for rejection were tracked between January 2010 and December 2013.
A total of 40,104 blood samples were received during this period, of which 706 (1.8%) were rejected for the following reasons: 382 (54.0%) unsigned samples, 235 (33.0%) mislabeled samples, 57 (8.0%) unsigned requisitions, 18 (2.5%) incorrect tubes, and 14 (1.9%) ABO discrepancies. Of the samples, 2.5% were rejected in the year prior to implementing the electronic ordering system compared with 1.2% in the year following implementation ( P < .0001).
Our data demonstrate that implementation of an electronic ordering system significantly decreased the rate of blood sample rejection.
评估电子医嘱系统对血型和筛查检测样本拒收率的影响，以及对4年期间ABO血型不符数量的影响。
2011年5月实施电子医嘱系统。在2010年1月至2013年12月期间追踪拒收率及拒收原因。
在此期间共接收40104份血样，其中706份（1.8%）因以下原因被拒收：382份（54.0%）样本未签名，235份（33.0%）样本标签错误，57份（8.0%）申请单未签名，18份（2.5%）试管错误，14份（1.9%）ABO血型不符。在这些样本中，实施电子医嘱系统前一年的拒收率为2.5%，实施后一年为1.2%（P < .0001）。
我们的数据表明，电子医嘱系统的实施显著降低了血样拒收率。
